Evidence map›Paper›PMID 35637348›Full record

ArticleNature metabolism2022

Author Correction: Glutamine synthetase licenses APC/C-mediated mitotic progression to drive cell growth.

Jiang-Sha Zhao, Shuo Shi, Hai-Yan Qu, Zuzana Keckesova, Zi-Jian Cao, Li-Xian Yang, Xiaofu Yu, Limin Feng, Zhong Shi, Joanna Krakowiak and 12 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

Jiang-Sha ZhaoZhejiang Provincial Key Laboratory of Pancreatic Disease, First Affiliated Hospital, and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China. zhaojsh@zju.edu.cn.ORCID http://orcid.org/0000-0002-3642-9269
Shuo ShiShanghai Advanced Institute of Immunochemical Studies, ShanghaiTech University, Shanghai, China.
Hai-Yan QuZhejiang Provincial Key Laboratory of Pancreatic Disease, First Affiliated Hospital, and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China.
Zuzana KeckesovaInstitute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czech Republic.
Zi-Jian CaoInstitute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China.
Li-Xian YangInstitute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China.
Xiaofu YuDepartment of Thoracic Radiotherapy, Institute of Cancer and Basic Medicine, Chinese Academy of Sciences, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China.
Limin FengZhejiang Provincial Key Laboratory of Pancreatic Disease, First Affiliated Hospital, and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China.
Zhong ShiDepartment of Medical Oncology, Institute of Cancer and Basic Medicine, Chinese Academy of Sciences, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China.
Joanna KrakowiakDepartment of Biochemistry and Molecular Biology, McGovern Medical School, University of Texas Health Science Center Houston, Houston, TX, USA.
Ruo-Ying MaoZhejiang Provincial Key Laboratory of Pancreatic Disease, First Affiliated Hospital, and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China.
Yi-Tong ShenInstitute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China.
Yu-Meng FanInstitute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China.
Tian-Min FuDepartment of Biological Chemistry and Pharmacology, College of Medicine, The Ohio State University, Ohio, OH, USA.ORCID http://orcid.org/0000-0002-6281-1752
Cunqi YeLife Sciences Institute, Zhejiang University, Hangzhou, China.
Daqian XuZhejiang Provincial Key Laboratory of Pancreatic Disease, First Affiliated Hospital, and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China.
Xiaofei GaoSchool of Life Sciences, Westlake University, Hangzhou, China.
Jia YouSchool of Life Sciences, Westlake University, Hangzhou, China.
Wenbo LiDepartment of Biochemistry and Molecular Biology, McGovern Medical School, University of Texas Health Science Center Houston, Houston, TX, USA.
Tingbo LiangZhejiang Provincial Key Laboratory of Pancreatic Disease, First Affiliated Hospital, and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China. liangtingbo@zju.edu.cn.
Zhimin LuZhejiang Provincial Key Laboratory of Pancreatic Disease, First Affiliated Hospital, and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China. zhiminlu@zju.edu.cn.
Yu-Xiong FengZhejiang Provincial Key Laboratory of Pancreatic Disease, First Affiliated Hospital, and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China. yxfeng@zju.edu.cn.ORCID http://orcid.org/0000-0002-9086-4448

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35637348

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.